British Scientists Develop Nasal Spray to Help Cut Covid Risks

Researchers at Aalborg University screen and analyze positive coronavirus samples for the virus variant cluster B117 from the United Kingdom, in Aalborg, Denmark, Jan. 15, 2021. (AFP Photo)
Researchers at Aalborg University screen and analyze positive coronavirus samples for the virus variant cluster B117 from the United Kingdom, in Aalborg, Denmark, Jan. 15, 2021. (AFP Photo)
TT

British Scientists Develop Nasal Spray to Help Cut Covid Risks

Researchers at Aalborg University screen and analyze positive coronavirus samples for the virus variant cluster B117 from the United Kingdom, in Aalborg, Denmark, Jan. 15, 2021. (AFP Photo)
Researchers at Aalborg University screen and analyze positive coronavirus samples for the virus variant cluster B117 from the United Kingdom, in Aalborg, Denmark, Jan. 15, 2021. (AFP Photo)

British scientists have developed an anti-viral nasal spray that dramatically cuts the chance of catching Covid. Two pumps in each nostril protect for up to eight hours, say its inventors. They believe the spray, pHOXWELL, could play a vital role in providing more protection for vulnerable patients in hospitals and care homes – and encourage workers to return to the office, The Daily Mail reported.

NHS heart surgeon and entrepreneur Professor Rakesh Uppal, chairman of Raphael Labs, the firm behind the invention, said it was "a significant breakthrough", adding that "we now have an effective tool, previously missing, to fight this pandemic. Vaccination, while absolutely essential, is not 100 percent effective and it is still possible to become infected by and transmit the virus that causes Covid-19."

He said the spray offered extra protection on top of vaccines and personal protection equipment (PPE) because it inhibited this virus, Sars-CoV-2, from infecting the mucus membrane in the nose – the main entry point to the body.
The spray was trialed on more than 600 unvaccinated health workers in India at the peak of its early summer wave. Those who received pHOXWELL were two-thirds less likely to become infected with Covid over a 45-day period than colleagues given a dummy spray.

The main aim is to help protect millions of people in developing countries who have been unable to get a Covid vaccine. The spray is easy to transport and store, being stable at room temperature. But it could also benefit people who have been jabbed – as vaccination does not provide perfect protection from infection.

Oxford University chemist Professor Angela Russell, who is one of pHOXWELL's inventors, said: "We think something like the spray could help us get the country back on its feet."

People would be able to come together in enclosed spaces with more confidence. You could see having the spray in your bag as common as having pills like paracetamol in case you get a headache.

Laboratory studies found the spray – which contains an active substance that is lethal to certain viruses but otherwise harmless – killed Sars-CoV-2 in 30 seconds. This prevents it from getting beyond mucus in the nose and thus into the body. It was also active against flu, killing it within five minutes.



Victory for Prince Harry as Murdoch Papers Admits Wrongdoing by Sun 

Britain's Prince Harry, Duke of Sussex steps out of a car, outside the Rolls Building of the High Court in London, Britain June 7, 2023. (Reuters)
Britain's Prince Harry, Duke of Sussex steps out of a car, outside the Rolls Building of the High Court in London, Britain June 7, 2023. (Reuters)
TT

Victory for Prince Harry as Murdoch Papers Admits Wrongdoing by Sun 

Britain's Prince Harry, Duke of Sussex steps out of a car, outside the Rolls Building of the High Court in London, Britain June 7, 2023. (Reuters)
Britain's Prince Harry, Duke of Sussex steps out of a car, outside the Rolls Building of the High Court in London, Britain June 7, 2023. (Reuters)

Prince Harry settled his privacy claim against Rupert Murdoch's UK newspaper group on Wednesday after the publisher admitted unlawful actions at its Sun tabloid for the first time, bringing the fiercely-contested legal battle to a dramatic end.

In a stunning victory for Harry, 40, the younger son of King Charles, News Group Newspapers (NGN), publisher of The Sun and the now-defunct News of the World, also admitted it had intruded into the private life of his late mother, Princess Diana.

Harry's lawyer, David Sherborne, said the publisher had agreed to pay the prince substantial damages. A source familiar with the settlement said it involved an eight-figure sum.

Harry had been suing NGN at the High Court in London, accusing its newspapers of unlawfully obtaining private information about him from 1996 until 2011.

The trial to consider the royal's case, and a similar lawsuit from former senior British lawmaker Tom Watson, was due to start on Tuesday but following last-gasp talks, the two sides reached a settlement, with NGN saying there had been wrongdoing at The Sun, something it had denied for years.

"NGN offers a full and unequivocal apology to the Duke of Sussex for the serious intrusion by The Sun between 1996 and 2011 into his private life, including incidents of unlawful activities carried out by private investigators working for The Sun," Sherborne said.

"NGN further apologizes to the Duke for the impact on him of the extensive coverage and serious intrusion into his private life as well as the private life of Diana, Princess of Wales, his late mother, in particular during his younger years."

ACCOUNTABILITY

NGN has paid out hundreds of millions of pounds to victims of phone-hacking and other unlawful information gathering by the News of the World, and settled more than 1,300 lawsuits involving celebrities, politicians, well-known sports figures and ordinary people who were connected to them or major events.

But it had always rejected any claims that there was wrongdoing at The Sun newspaper, or that any senior figures knew about it or tried to cover it up, as Harry's lawsuit alleges.

Harry said his mission was to get the truth and accountability, after other claimants settled cases to avoid the risk of a multi-million-pound legal bill that could be imposed even if they won in court but rejected NGN's offer.

He said the reason he had not settled was because his lawsuit was not about money, but because he wanted the publishers' executives and editors to be held to account and to admit their wrongdoing.